Economic evaluation of donepezil in moderate to severe Alzheimer disease

被引：0
|
作者：
van Hout, HPJ
Bosmans, JE
Stalman, WAB
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 07期
关键词：
D O I：
10.1212/WNL.64.7.1320
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1320 / 1320
页数：1
相关论文
共 50 条
  • [21] Donepezil in patients with severe alzheimer’s disease
    Karen Marder
    Current Neurology and Neuroscience Reports, 2006, 6 (5) : 363 - 364
  • [22] Donepezil for severe Alzheimer's disease - Reply
    Winblad, Bengt
    LANCET, 2006, 368 (9533): : 362 - 362
  • [23] Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
    Waldemar, G.
    Hyvarinen, M.
    Wetterberg, P.
    Korner, A.
    Lehto, H.
    Josiassen, M. K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 188 - 188
  • [24] Memantine enhances autonomy in moderate to severe Alzheimer's disease patients already receiving donepezil
    Wirth, Y.
    Rive, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 474 - 474
  • [25] Effects of donepezil in patients with moderate-to-severe Alzheimer's disease discontinuing memantine monotherapy
    Sakka, P.
    Tsolaki, M.
    Hort, J.
    Hager, K.
    Soininen, H.
    Lopez-Pousa, S.
    Li, C.
    Schwam, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 58 - 58
  • [26] Efficacy of donepezil on functional, behavioral, and cognitive symptoms in patients with moderate to severe Alzheimer's disease
    Gauthier, S
    Feldman, H
    Hecker, J
    Vellas, B
    Subbiah, P
    Whalen, E
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S2 - S2
  • [27] Effect of memantine treatment at patients with moderate-severe Alzheimer's disease treated with Donepezil
    Szalontay, A. S.
    Chirita, R.
    Chirita, V.
    EUROPEAN PSYCHIATRY, 2008, 23 : S198 - S198
  • [28] Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
    Waldemar, Gunhild
    Hyvarinen, Maritta
    Josiassen, Mette Krog
    Korner, Alex
    Lehto, Heikki
    Wetterberg, Peter
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (09) : 979 - 981
  • [29] Memantine/donepezil dual-therapy is superior to placebo/donepezil therapy for treatment of moderate to severe Alzheimer's disease.
    Tariot, R
    Farlow, M
    Grossberg, G
    Gergel, I
    Graham, S
    Jin, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S225 - S226
  • [30] Donepezil versus vitamin E in Alzheimer's disease - Part 2: Mild versus moderate-severe Alzheimer's disease
    Onofrj, M
    Thomas, A
    Luciano, AL
    Iacono, D
    Di Rollo, A
    D'Andreamatteo, G
    Di Iorio, A
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (04) : 207 - 215
12345